Human tissue kallikrein gene family: applications in cancer

被引:109
作者
Obiezu, CV
Diamandis, EP
机构
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
kallikreins; serine proteases; cancer; biomarkers; prognosis; diagnosis; tumor invasion and metastasis;
D O I
10.1016/j.canlet.2004.09.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human tissue kallikrein genes, located on the long arm of chromosome 19, are a subgroup of the serine protease family of proteolytic enzymes. Initially thought to consist of three members, the human kallikrein locus has now been extended and includes 15 tandemly located genes. These genes, and their protein products, share a high degree of homology and are expressed in a wide array of tissues, mainly those that are under steroid hormone control. PSA (hK3) is one of the human kallikreins, and is the most useful tumor marker for prostate cancer screening, diagnosis, prognosis and monitoring. hK2, another prostate-specific kallikrein, has also been proposed as a complementary prostate cancer biomarker. In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been associated with several types of cancer. For example, hK4, hK5, hK6, hK7, hK8, hK10, hK11, hK13 and hK14 are emerging biomarkers for ovarian, breast, prostate and testicular cancer. New evidence raises the possibility that some kallikreins are directly involved with cancer progression. We here review the evidence linking kallikreins and cancer and their applicability as novel biomarkers for cancer diagnosis and management. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 22
页数:22
相关论文
共 208 条
[81]   Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer [J].
Kim, H ;
Scorilas, A ;
Katsaros, D ;
Yousef, GM ;
Massobrio, M ;
Fracchioli, S ;
Piccinno, R ;
Gordini, G ;
Diamandis, EP .
BRITISH JOURNAL OF CANCER, 2001, 84 (05) :643-650
[82]  
Kishi T, 2003, CANCER RES, V63, P2771
[83]   Human kallikrein 8: Immunoassay development and identification in tissue extracts and biological fluids [J].
Kishi, T ;
Grass, L ;
Soosaipillai, A ;
Shimizu-Okabe, C ;
Diamandis, EP .
CLINICAL CHEMISTRY, 2003, 49 (01) :87-96
[84]   Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages [J].
Komatsu, N ;
Takata, M ;
Otsuki, N ;
Toyama, T ;
Ohka, R ;
Takehara, K ;
Saijoh, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (03) :542-549
[85]   Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples [J].
Kuwae, K ;
Matsumoto-Miyai, K ;
Yoshida, S ;
Sadayama, T ;
Yoshikawa, K ;
Hosokawa, K ;
Shiosaka, S .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2002, 55 (04) :235-241
[86]   Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer [J].
Kyriakopoulou, LG ;
Yousef, GM ;
Scorilas, A ;
Kaatsaros, D ;
Massobrio, M ;
Fracchioli, S ;
Diamandis, EP .
CLINICAL BIOCHEMISTRY, 2003, 36 (02) :135-143
[87]  
Li B, 2001, CANCER RES, V61, P8014
[88]   Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain [J].
Little, SP ;
Dixon, EP ;
Norris, F ;
Buckley, W ;
Becker, GW ;
Johnson, M ;
Dobbins, JR ;
Wyrick, T ;
Miller, JR ;
MacKellar, W ;
Hepburn, D ;
Corvalan, J ;
McClure, D ;
Liu, XD ;
Stephenson, D ;
Clemens, J ;
Johnstone, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25135-25142
[89]  
Liu XL, 1996, CANCER RES, V56, P3371
[90]   Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2 [J].
Lovgren, J ;
Rajakoski, K ;
Karp, M ;
Lundwall, A ;
Lilja, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (02) :549-555